Pfizer’s CEO Jeff Kindler is hitting the road. The official story is that Kindler is leaving to “spend time with his family.” It’s a pretty typical excuse. This certainly has all the hallmarks of being ousted by the Board (especially since the company’s Board will appoint a non-executive Director in an upcoming Board meeting).
Kindler will be replaced by Ian Read, who heads the global pharmaceuticals business for Pfizer.
